Risk Factors and Oncologic Outcomes for Clinical T1 Renal Cell Carcinoma Upstaging to Pathological T3a and The Construction of Predictive Model: A Retrospective Study Predictors of upstaging to pT3a in renal carcinoma
Vol. 20 No. 03 (2023),
21 May 2023
Purpose: The study is intended to identify the independent predictors of clinical T1 (cT1) renal cell carcinoma upstaging to pathological T3a (pT3a) and construct the predictive nomogram model.
Methods: The data of cT1 renal cell carcinoma was collected from patients who were treated in the Second Hospital of Tianjin Medical University from January 2010 to December 2016. Mann–Whitney U and chi-square tests were performed to analyze continuous and categorical variables respectively. Univariate and multivariate logistic regression were used to identify the predictors of upstaging. Kaplan-Meier method, log-rank test and Cox regression were performed to analyze survival materials.
Results: Among 1,376 cT1 renal cell carcinoma patients, 75 patients were observed upstaging to pT3a, accounting for 5.5%. There were 6 potential predictors of upstaging, i.e age, clinical symptom, tumor size, Fuhrman grade, tumor necrosis and tumor edge regularity. The 5-year recurrence free survival probabilities of upstaging and non-upstaging patients were 73.3% and 91.1%, respectively and upstaging was an independent predictor of recurrence free survival. Two predictive nomograms were constructed and the C-index of them were 0.842 and 0.806, and the calibration curve and decision curve analysis showed highly clinical accuracy of the nomograms.
Conclusion: Two nomogram models were built to predict the probability of cT1 renal cell carcinoma upstaging to pT3a with highly accuracy and specificity. Upstaging was an independent risk factor of recurrence free survival for cT1 renal cell carcinoma patients.
- Carcinoma, renal cell, upstaging, recurrence free survival, risk factor, nomogram
How to Cite
Williamson SR, Taneja K, Cheng L. Renal cell carcinoma staging: pitfalls, challenges, and updates. Histopathology. 2019; 74: 18-30.
Rinott Mizrahi G, Freifeld Y, Klein I, et al. Comparison of partial and radical laparascopic nephrectomy: perioperative and oncologic outcomes for clinical T2 renal cell carcinoma. J Endourol. 2018; 32: 950-4.
Sokhi HK, Mok WY, Patel U. Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion. Br J Radiol. 2015; 88: 20140504.
Ramaswamy K, Kheterpal E, Pham H, et al. Significance of pathologic T3a upstaging in clinical T1 renal masses undergoing nephrectomy. Clin Genitourin Cancer. 2015; 13: 344-9.
Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015; 67: 913-24.
Gorin MA, Ball MW, Pierorazio PM, et al. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis. J Urol. 2013; 190: 1907-11.
Nayak JG, Patel P, Saarela O, et al. Pathological upstaging of clinical T1 to pathological T3a renal cell carcinoma: A multi-institutional analysis of short-term outcomes. Urology. 2016; 94: 154-60.
Veccia A, Falagario U, Martini A, et al. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: A systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus. 2021; 7: 574-81.
Ghanie A, Formica MK, Wang D, Bratslavsky G, Stewart T. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013. Int Urol Nephrol. 2018; 50: 237-45.
Lee H, Lee M, Lee SE, et al. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy. BMC Cancer. 2018; 18: 427.
Jeong SH, Kim JK, Park J, et al. Pathological T3a upstaging of clinical T1 renal cell carcinoma: outcomes according to surgical technique and predictors of upstaging. PLoS One. 2016; 11: e0166183.
Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008; 15: 1375-82.
Jeong SU, Park JM, Shin SJ, et al. Prognostic significance of macroscopic appearance in clear cell renal cell carcinoma and its metastasis-predicting model. Pathol Int. 2017; 67: 610-9.
Li G, Xiao T, Wang K, et al. Histopathological validation of safe margin for nephron-sparing surgery based on individual tumor growth pattern. World J Surg Oncol. 2021; 19: 255.
Collins J, Epstein JI. Prognostic significance of extensive necrosis in renal cell carcinoma. Hum Pathol. 2017; 66: 108-14.
Chen L, Ma X, Li H, et al. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy. PLoS One. 2017; 12: e0173953.
Li L, Shi L, Zhang J, Fan Y, Li Q. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage. Cancer Med. 2021; 10: 605-614.
Lam JS, Klatte T, Patard JJ, et al. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol. 2007; 52: 155-62.
Rothberg MB, Paulucci DJ, Okhawere KE, et al. A multi-institutional analysis of the effect of positive surgical margins following robot-assisted partial nephrectomy on oncologic outcomes. J Endourol. 2020; 34: 304-11.
Ryan ST, Patel DN, Ghali F, et al. Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database. Minerva Urol Nephrol. 2021; 73: 233-44.
Tellini R, Antonelli A, Tardanico R, et al. Positive surgical margins predict progression-free survival after nephron-sparing surgery for renal cell carcinoma: Results from a single center cohort of 459 cases with a minimum follow-up of 5 Years. Clin Genitourin Cancer. 2019; 17: e26-e31.
Wang HK, Zhu Y, Yao XD, et al. External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma. J Urol. 2012; 187: 1555-60.
Tay MH, Thamboo TP, Wu FM, et al. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery. J Endourol. 2014; 28: 1138-42.
Lai GS, Li JR, Wang SS, et al. Survival analysis of pathological T3a upstaging in clinical T1 renal cell carcinoma. In Vivo. 2020; 34: 799-805.
Cao C, Kang X, Shang B, et al. A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma. Int Braz J Urol. 2022; 48: 784-94.
- Abstract Viewed: 141 times
- 7294/pdf Downloaded: 128 times